Salesforce
CRM
$256.93
-0.46%
Salesforce, Inc. is a leading provider of enterprise cloud computing solutions, primarily known for its Customer 360 platform that integrates customer relationship management (CRM) technology across sales, service, marketing, and commerce. As a dominant player in the CRM software market, Salesforce differentiates itself through its comprehensive suite of cloud-based applications and its strategic focus on AI-driven innovations like Agentforce. The current investor narrative centers on Salesforce's robust growth in its core business, highlighted by a 16% increase in revenue, and the significant contribution from its investment in Anthropic, which has fueled a surge in the stock price. The company's record $27 billion stock buyback program and its recent $1.6 billion federal AI contract underscore management's confidence and the market's optimism about its AI-driven growth trajectory.…
CRM
Salesforce
$256.93
Related headlines
Investment Opinion: Should I buy CRM Today?
Rating: Buy. Salesforce is a high-quality growth company with a strong competitive position in CRM and a clear AI strategy. The analyst consensus is a Buy with an average target of $244.02, implying a -4.7% downside from the current price, but the high target of $475 suggests significant upside potential if AI initiatives succeed.
Sign up to view all
CRM 12-Month Price Forecast
The AI-driven growth narrative is compelling, with Agentforce gaining traction and the Anthropic stake providing a windfall. However, the recent stock surge has pushed the price above the average analyst target, limiting near-term upside. I would upgrade to a more bullish stance if the stock pulls back to below $220 or if Agentforce revenue exceeds expectations. Conversely, a downgrade to neutral would occur if revenue growth decelerates below 10% or if the stock fails to hold above $200.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Salesforce's 12-month outlook, with a consensus price target around $269.48 and implied upside of +4.9% versus the current price.
Average Target
$269.48
0 analysts
Implied Upside
+4.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$160 - $475
Analyst target range
The target price range spans from a low of $160 to a high of $475, reflecting a wide dispersion of expectations. The high target of $475 suggests that some analysts anticipate substantial upside, possibly driven by AI-driven growth and successful monetization of Agentforce. The low target of $160 may reflect concerns about competitive pressures or a potential slowdown in growth. Recent institutional actions show a mix of upgrades and downgrades, with firms like Guggenheim upgrading from Neutral to Buy and Keybanc downgrading from Overweight to Sector Weight, indicating some divergence in sentiment. The wide range and mixed actions highlight uncertainty about Salesforce's future performance, but the overall consensus remains positive.
Drowning in data?
Find the real signal!
Bulls vs Bears: CRM Investment Factors
Salesforce presents a compelling bull case with accelerating revenue growth, strong profitability, and AI-driven catalysts like Agentforce and the Anthropic stake. However, the bear case highlights dependence on non-core gains, competitive threats, and a valuation that may already price in much of the optimism. Currently, the bull case has stronger evidence given the robust fundamental performance and strategic positioning in AI, but the key tension is whether the recent stock surge (up 35.9% in one month) has outpaced the fundamental improvement. If AI monetization continues to deliver and revenue growth accelerates, the stock has further upside; if not, the stock could correct toward the analyst average target.
Bullish
- Accelerating Revenue Growth: Q1 FY2027 revenue grew 13.3% YoY to $11.13B, up from 9.8% in Q1 FY2026, indicating accelerating momentum. The multi-quarter trend shows consistent growth from $9.83B to $11.13B, driven by strong Subscription and Support revenue.
- AI Monetization via Agentforce: The $1.6B federal AI contract with the VA validates Agentforce demand, moving from pilot to procurement. This signals a tangible revenue stream from AI, a key growth catalyst.
- Record $27B Buyback: Management's record $27B stock buyback in a single quarter demonstrates strong confidence in future cash flows and earnings growth. This aggressive capital return program supports EPS growth and signals undervaluation.
- Strong Profitability Metrics: Operating margin improved to 21.8% in Q1 FY2027, up from 19.8% a year ago. Net margin also expanded to 18.9%, reflecting efficient cost management and operating leverage.
Bearish
- Dependence on Anthropic Stake: The recent stock surge was largely fueled by a $2.7B gain from its Anthropic investment, not core operations. This non-recurring gain inflates earnings and may not be sustainable, raising concerns about earnings quality.
- High Valuation vs. Growth: Despite the forward PE of 16.19x, the PEG ratio of 1.24 suggests the stock is fairly valued to slightly overvalued relative to its growth rate. The market cap of $201.7B is high, and any growth deceleration could lead to multiple compression.
- Competitive Pressures: ServiceNow's explosive agentic AI growth signals a competitive threat in the enterprise software space. If ServiceNow or Microsoft gains share, Salesforce's growth could slow, impacting its premium valuation.
- Macro Sensitivity: With a beta of 1.15, Salesforce is more volatile than the market. In a rising rate environment or economic downturn, the stock could underperform, as seen in its -44.45% max drawdown.
CRM Technical Analysis
Salesforce's stock has exhibited a strong recovery from its 52-week low of $146.32, currently trading at $256, which is 95% of its 52-week range (between $146.32 and $269.11). The 1-year price change is a modest +0.58%, but this masks a dramatic turnaround from a significant drawdown of -44.45% earlier in the period. The stock's position near the high end of its range suggests renewed momentum and investor confidence, though it may also indicate short-term overextension.
Beta
1.15
1.15x market volatility
Max Drawdown
-43.9%
Largest decline past year
52-Week Range
$146-$269
Price range past year
Annual Return
+1.6%
Cumulative gain past year
| Period | CRM Return | S&P 500 |
|---|---|---|
| 1m | +38.2% | +1.0% |
| 3m | +36.1% | +1.1% |
| 6m | +27.1% | +13.8% |
| 1y | +1.6% | +19.5% |
| ytd | +1.3% | +12.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRM Fundamental Analysis
Salesforce's revenue growth has been robust, with the most recent quarter (Q1 FY2027) reporting revenue of $11.13 billion, a 13.3% year-over-year increase. This growth is driven by the Subscription and Support segment, which contributed $10.59 billion, while Professional Services added $0.54 billion. The multi-quarter trend shows accelerating growth, with revenue rising from $9.83 billion in Q1 FY2026 to $11.13 billion in Q1 FY2027, indicating a consistent upward trajectory.
Quarterly Revenue
$11.1B
2026-04
Revenue YoY Growth
+13.3%
YoY Comparison
Gross Margin
76.9%
Latest Quarter
Free Cash Flow
$14.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRM Overvalued?
Given Salesforce's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 27.04x, while the forward PE is 16.19x, indicating that the market expects significant earnings growth. The gap between trailing and forward PE suggests that the market is pricing in a substantial increase in earnings, likely driven by AI-related opportunities and margin expansion.
PE
27.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~247x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks include Salesforce's reliance on continued revenue growth to justify its valuation. The company's debt-to-equity ratio of 0.29 is manageable, but its current ratio of 0.76 indicates potential liquidity concerns. The $2.7B gain from Anthropic is non-operating and may not recur, making earnings less predictable. Additionally, the record $27B buyback, while signaling confidence, also reduces cash reserves that could be needed for strategic investments or downturns.
